Seroquel, Quetiapine News

Here's a quick look at some atypical antipsychotics prescribed for young people: Risperidone Risperidone, sold under the trade name Risperdal in the United States and Canada, changes the effects of chemicals in the brain, and is used to treat schizophrenia as well as symptoms of bipolar disorder.

Medical research out of the University of British Columbia suggests the number of children taking medications known as atypical antipsychotics has increased tenfold over the past decade, CBC News has learned.

In Massachusetts, a four-year-old girl named Rebecca became the center of a murder investigation after being found dead from an overdose of a dangerous combination of drugs.

Seroquel is an antipsychotic medication used in the treatment of bipolar disorder and schizophrenia, as well as for off-label conditions such as sleep problems.

Even as a US District Court prepares 6,000 Seroquel lawsuits for trial, Eli Lilly pays $1.42 billion for illegal Zyrexa marketing and 30 states sue over heisted Medicaid funds for atypical antipsychotics, an FDA advisory panel has recommended approval of Seroquel, Zyrexa and Geodon for children.

Seroquel was voted to be "acceptably safe" and effective for the treatment of schizophrenia in teenagers, said a U.S. Food and Drug Administration panel of outside medical experts that reviews such indications for the FDA.

A panel of medical experts for the federal Food and Drug Administration is being asked to approve three powerful and expensive antipsychotic drugs for use in children.

Three antipsychotic drugs appear to work in children and teens but their risks must be weighed as the makers aim to promote the medicines for youth, U.S. drug reviewers said in documents released on Friday.

Three antipsychotic drugs appear to work in children and teens but their risks must be weighed as the makers aim to promote the medicines for youth, U.S. drug reviewers said in documents released on Friday.

AstraZeneca has has referred its application for SEROQUEL XR Extended Release Tablets for the treatment of recurrent depressive episodes in adult patients with major depressive disorder to the Committee for Medicinal Products for Human Use .

FDA Panel Issues Mixed Decision on Quetiapine in Depression and Anxiety JAMA. 2009;301 :2081-2082. A new formulation of extended-release quetiapine, an atypical antipsychotic medication, should not be approved as a monotherapy for major depressive disorder and generalized anxiety disorder because of serious cardiac and metabolic adverse events ...

Results presented today at the 162nd American Psychiatric Association congress in San Francisco, CA, demonstrated the efficacy and tolerability of SEROQUEL for treating depressive episodes in bipolar disorder, including the difficult-to-treat bipolar II patient population.1,2 The data are from combined analyses of four large-scale clinical trials ...

Yesterday's release of more AstraZeneca documents in the federal Seroquel litigation provided yet another batch of letters from Wayne MacFadden , psychiatry's greatest lover.

Continuing their groundbreaking research into the treatment of mood disorders in older adults, psychiatrists at the Weill Cornell Institute of Geriatric Psychiatry at the NewYork-Presbyterian Hospital/Westchester Division in White Plains will begin new studies on the effects of quetiapine and lamotrigine .

FDA advisers who met in April to discuss broadening the labeling of Seroquel XR, AstraZeneca's extended-release formulation of quetiapine fumarate, unanimously agreed that the drug should not be used as a first-line monotherapy for major depressive disorder or generalized anxiety disorder .

Sanofi-Aventis and Bristol-Myers Squibb have agreed to work with the FDA to conduct studies of clopidogrel bisulfate that will allow a better understanding of genetic factors, as well as the effects of other drugs-especially proton pump inhibitors -on the effectiveness of clopidogrel.

WALTHAM,A Mass. Psychiatrists treating patients with bipolar depression base their prescribing decisions on a therapya s effect on decrease in severity of depressive symptoms, a report released Monday has found.

Atypical antipsychotic medications are associated with weight gain and other metabolic changes among patients with Alzheimer's disease, according to a recent analysis of data from the NIMH-funded Clinical Antipsychotic Trials of Intervention Effectivenessa 'Alzheimer's Disease study.

About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome mood swings.

AstraZeneca PLC won partial support from U.S. advisers on Wednesday for its bid to expand the approved uses of its schizophrenia drug Seroquel XR, known generically as quetiapine.